Epigenetic alterations relating to histone methylation (KMT2D, KMT2C, EZH2), histone acetylation (CREBBP, EP300), and DNA methylation (TET2) play an important role in tumor progression for FL and DLBCL. The gene discussed is TET2; the disease is diffuse large B-cell lymphoma.